Rural Cancer Care Delivery in the United States: A 2026 Update on Disparities, Vulnerable Populations, and Emerging Models

Rural Americans with cancer face persistent and widening disparities in incidence, stage at diagnosis, treatment access, and mortality. This paper synthesizes evidence on the financial sustainability of rural oncology programs, the populations bearing the greatest burden of rural cancer disparities, and the care delivery models most likely to narrow those gaps. We conducted a narrative review of English-language literature published through early 2026, drawing from peer-reviewed articles, national surveillance data, ASCO abstracts, and policy analyses. Rural oncology programs face significant financial challenges: 85% of rural hospitals are strained or vulnerable, cancer services at critical access hospitals (CAHs) have declined, and the 340B Drug Pricing Program's orphan-drug exclusion for CAHs represents an underappreciated structural gap that undermines program sustainability for the facilities most dependent on it. Rural-urban cancer mortality gaps are widest among adults younger than 65 years (the age paradox), who lack Medicare's partial safety net. Racial and ethnic minorities in rural areas, particularly Black Americans and American Indian/Alaska Natives, face compounding geographic and structural barriers. Counter to longstanding assumptions, the per-capita supply of rural oncologists grew approximately 20% nationally from 2012 to 2022, with 67% growth in the most isolated areas. Several models show promise, including hub-and-spoke networks, teleoncology, Project Extension for Community Healthcare Outcomes (ECHO) telementoring, CAH-based programs, patient navigation, oncology hospital-at-home, and National Cancer Institute Community Oncology Research Program (NCORP) sites. However, a key paradox persists: regions with the poorest geographic access to cancer centers have the lowest telehealth utilization rates. Rural cancer disparities are fundamentally a policy and equity problem, not a technology or geography problem. Proven delivery models exist, but they require concurrent policy investment to realize their full potential. Closing the gap requires permanent telehealth authorization, with payment parity, Medicaid expansion, advanced practice provider workforce investment, targeted 340B reform for CAHs, and interstate licensure reform. Oncologists and health systems have both the evidence and the ethical obligation to advocate for these changes, including through participation in hub-and-spoke affiliate networks, NCORP sites, or ECHO programs in their own communities.